Skip to content

Methodds closes the gap between data science and medicine by providing state-of-the-art solutions and expert services in healthcare


Machine Learning


Drug Efficacy


Pharmacology & Toxicology

Healthcare Communication


Adrian Martinez de la Torre, PhD

CEO and Cofounder

Adrian did his PhD in Biostatistics and Machine Learning in the Pharmacoepidemiology Group at the ETH Zurich. He holds a B.Sc. in Economics and Methods of Quantitative Analysis from Universitat Pompeu Fabra in Barcelona, and a M.Sc. in Econometrics from Erasmus University Rotterdam. He previously worked as Lead Biostatistician of the Digestive and Liver Diseases group at Vall d’Hebron Research Institute (VHIR), as a Data Scientist at Heygo, a Spanish digital startup, and as a Researcher at SKIM in Rotterdam, the Netherlands. Adrian has a strong focus on advanced statistical methods and applied machine learning in a wide range of areas such as drug safety, drug efficacy, drug utilization, sports medicine, or clinical trials.

PD Stefan Weiler, MD, PhD

Chief Medical Officer (CMO) and Cofounder

Stefan is a Medical Doctor with specializations in Clinical Pharmacology, Toxicology, and General Internal Medicine. He holds a PhD in Medical Sciences and a Master in Health Business Administration (MHBA). He is a Senior Physician at the University Hospital Bern, Inselspital. He is a lecturer, PrivatDozent (PD) at the University of Zurich and Senior Scientist in the Pharmacoepidemiology group at ETH Zurich and is a member of the Human Medicines Expert Committee (HMEC) of Swissmedic. Previously, he has worked for three years as the Scientific Expert in the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. He was Scientific Director at the Swiss National Poisons Center (Tox Info Suisse). Stefan is currently in the editorial and advisory board of different scientific journals. He has more than 170 scientific publications in the field of pharmacology and drug safety in high impact journals such as in the New England Journal of Medicine, British Medical Journal, and JAMA.

Advisory Board

Prof. Dr. Andrea Burden

Prof. Burden is currently an Assistant Professor in Pharmacoepidemiology at the ETH Zurich. She holds a PhD in Pharmacoepidemiology from the University of Toronto and worked in the University of Maastricht as a postdoc in Pharmacoepidemiology. She is a faculty member of the ETH AI Center. Her areas of expertise lie in the intersection of drug safety, drug efficacy, and drug utilization research with a strong focus on advanced applied statistical methodologies. She is a founding member of the European Calcified Tissue Society (ECTS) Academy and in 2021 Prof. Burden received the Emerging Leader in Pharmaceutical Sciences Alumni Award from the Leslie Dan Faculty of Pharmacy of the University of Toronto.

Prof. Dr. Fernando Perez-Cruz

Prof. Perez-Cruz is the Deputy Executive Director of the Swiss Data Science Center (SDSC) since 2017. He received a PhD. in Electrical Engineering from the Technical University of Madrid. He has been a member of the technical staff at Bell Labs and a Machine Learning Research Scientist at Amazon. Fernando has been a visiting professor at Princeton University under a Marie Curie Fellowship and an associate professor at University Carlos III in Madrid. He held positions at the Gatsby Unit (London), Max Planck Institute for Biological Cybernetics (Tuebingen), and BioWulf Technologies (New York).


Hugo Kupferschmidt, MD, MBA

Hugo Kupferschmidt, MD, eMBA-HSG, medical specialist in Internal Medicine and Clinical Pharmacology and Toxicology, is a Clinical Toxicologist with many years of experience in the area of poisoning and overdose. He was head of the Swiss Poisons Information Centre (Tox Info Suisse) 2004-2021, and is currently the head of the Berlin Poisons Centre at the Charité – University Medicine, Germany. He is a former president of the European Association of Poisons Centres and Clinical Toxicologists, and of the Swiss Society of Clinical Pharmacology and Toxicology.

Patrik Ferrarelli

Patrik is since 2008 the founder of the Visual Communication Studio, which implements various design and consulting mandates in the economic, cultural and academic fields. In addition to this, he is also a Scientific Assistant and lecturer at the Zurich University of Arts (ZHdK) and DHBW Mediendesign Ravensburg (Germany). Patrik studied visual communication at the University of Art and Design in Zurich and Bern University of Applied Sciences. Before his studies, he worked at the Institute for Virtual Production at ETH Zurich under Prof. Dr. Josef Reissner, where he was responsible for the conception and design of a multimedia lecture consisting of ten dissertations. During his studies he worked at Minddesign in London, where he realized projects in the field of visual identity and visual systems.

Get in touch!

We look forward to meeting you in person and presenting solutions to complex challenges.